Research programme: antiretroviral intravaginal rings - Auritec
Latest Information Update: 15 May 2015
At a glance
- Originator Auritec Pharmaceuticals
- Class Antiretrovirals
- Mechanism of Action CCR5 receptor antagonists; Nucleoside reverse transcriptase inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical HIV infections